Showing results (301-310 of 7,002) with videos related to

Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|January 20, 2020
A systematic review of survival following anti-cancer treatment for small cell lung cancerGavin S Jones, Kelly Elimian, David R Baldwin, et al.
Lung Cancer (Amsterdam, Netherlands)|January 20, 2020
Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA studySeiji Niho, Tatsuya Yoshida, Tetsuo Akimoto, et al.
Lung Cancer (Amsterdam, Netherlands)|January 21, 2020
COPD and lung cancer incidence in the Women's Health Initiative Observational Study: A brief reportMisako Nagasaka, Amy Lehman, Rowan Chlebowski, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2019
Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysisAaron C Tan, Gillianne G Y Lai, Gek San Tan, et al.
Lung Cancer (Amsterdam, Netherlands)|December 17, 2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France projectMichèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2020
Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explantsAlexander J Vickers, Kristopher Frese, Melanie Galvin, et al.
Lung Cancer (Amsterdam, Netherlands)|November 23, 2020
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancerThierry Berghmans, Yolande Lievens, Matti Aapro, et al.
Lung Cancer (Amsterdam, Netherlands)|November 13, 2020
Quality of life with adjuvant gefitinib versus vinorelbine plus cisplatin in patients with completely resected stage II-IIIA (N1-N2) EGFR-mutant non-small-cell lung cancer: Results from the ADJUVANT (CTONG1104) studyJian Zeng, Wei-Min Mao, Qi-Xun Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|September 5, 2020
Characterization of MET exon 14 alteration and association with clinical outcomes of crizotinib in Chinese lung cancersHaiyan Yang, Zhen Zhou, Li Lin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 19, 2020
Re-biopsy after first line treatment in advanced NSCLC can reveal changes in PD-L1 expressionMalene Støchkel Frank, Uffe Bødtger, Asbjørn Høegholm, et al.
Pageof 701